Lead Product(s) : PKM-02
Therapeutic Area : Genetic Disease
Sponsor : Bpifrance
Deal Size : $1.6 million
Deal Type : Financing
PK MED Receives €1.5M DeepTech Financing from Bpifrance for Cell-Homing Implant
Details : The funding will accelerate the company’s PKM-02, an innovative technology aiming to enhance bone marrow transplantation in several diseases with high unmet medical need such as hemoglobinopathies.
Brand Name : PKM-02
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
July 24, 2024
Lead Product(s) : PKM-02
Therapeutic Area : Genetic Disease
Sponsor : Bpifrance
Deal Size : $1.6 million
Deal Type : Financing
LOOKING FOR A SUPPLIER?